Tuberculosis (Scotland) Amendment Order 2022: business and regulatory impact assessment
A business and regulatory impact assessment (BRIA) for the Tuberculosis (Scotland) Amendment Order 2022.
Competition Assessment
These amendments to the Tuberculosis Order will not impact negatively on competition within the sector.
- Will the measures directly or indirectly limit the number or range of suppliers?: No
- Will the measures limit the ability of suppliers to compete?: No
- Will the measures limit suppliers' incentives to compete vigorously?: No
- Will the measure limit the choices and information available to consumers?: No
Contact
Email: animal.health@gov.scot
There is a problem
Thanks for your feedback